Header Logo

Connection

Neil Forbes to Bacteria

This is a "connection" page, showing publications Neil Forbes has written about Bacteria.
Connection Strength

1.858
  1. Forbes NS, Coffin RS, Deng L, Evgin L, Fiering S, Giacalone M, Gravekamp C, Gulley JL, Gunn H, Hoffman RM, Kaur B, Liu K, Lyerly HK, Marciscano AE, Moradian E, Ruppel S, Saltzman DA, Tattersall PJ, Thorne S, Vile RG, Zhang HH, Zhou S, McFadden G. White paper on microbial anti-cancer therapy and prevention. J Immunother Cancer. 2018 08 06; 6(1):78.
    View in: PubMed
    Score: 0.496
  2. Brackett EL, Swofford CA, Forbes NS. Microfluidic Device to Quantify the Behavior of Therapeutic Bacteria in Three-Dimensional Tumor Tissue. Methods Mol Biol. 2016; 1409:35-48.
    View in: PubMed
    Score: 0.414
  3. Van Dessel N, Swofford CA, Forbes NS. Potent and tumor specific: arming bacteria with therapeutic proteins. Ther Deliv. 2015 Mar; 6(3):385-99.
    View in: PubMed
    Score: 0.391
  4. Manole S, Nguyen DH, Min JJ, Zhou S, Forbes N. Setting "cold" tumors on fire: Cancer therapy with live tumor-targeting bacteria. Med. 2025 Jan 10; 6(1):100549.
    View in: PubMed
    Score: 0.193
  5. Sharma A, Raman V, Lee J, Forbes NS. Microbial Imbalance Induces Inflammation by Promoting Salmonella Penetration through the Mucosal Barrier. ACS Infect Dis. 2022 05 13; 8(5):969-981.
    View in: PubMed
    Score: 0.160
  6. Sharma A, Raman V, Lee J, Forbes NS. Mucus blocks probiotics but increases penetration of motile pathogens and induces TNF-a and IL-8 secretion. Biotechnol Bioeng. 2020 08; 117(8):2540-2555.
    View in: PubMed
    Score: 0.141
  7. Walsh CL, Babin BM, Kasinskas RW, Foster JA, McGarry MJ, Forbes NS. A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeutics. Lab Chip. 2009 Feb 21; 9(4):545-54.
    View in: PubMed
    Score: 0.063
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.